Nobel biocare receives fda 510(k) clearance for the nobel biocare n1™ implant system

Brea, calif., dec. 27, 2021 /prnewswire/ -- envista holdings corporation (nyse: nvst) ("envista") today announced that the u.s. food and drug administration (fda) has cleared the nobel biocare n1™ implant system.

NVST Ratings Summary

NVST Quant Ranking